journal
MENU ▼
Read by QxMD icon Read
search

Cardiovascular Diabetology

journal
https://www.readbyqxmd.com/read/30007407/triglyceride-mediated-influence-of-serum-angiopoietin-like-protein-8-on-subclinical-atherosclerosis-in-type-2-diabetic-patients-results-from-the-gdmd-study-in-china
#1
Tianpeng Zheng, Bo Ge, Hongbo Liu, Bo Chen, Linyuan Qin, Liuping Xiao, Jianfei Song
BACKGROUND: Hypertriglyceridemia, insulin resistance and hyperglycemia are risk factors for atherosclerosis in type 2 diabetes. Angiopoietin-like protein 8 (ANGPTL8) is a newly identified liver-derived hormone related to these risk factors. Hence, we aimed to explore the correlations between serum levels of ANGPTL8 and subclinical atherosclerosis in type 2 diabetes. METHODS: We measured serum ANGPTL8, blood lipids, blood glucose, common carotid artery Intima-Media Thickness (c-IMT) and calculated homeostasis model assessment of insulin resistance in (1) control subjects (n = 100), (2) type 2 diabetic patients without subclinical atherosclerosis (n = 100), and (3) type 2 diabetic patients with subclinical atherosclerosis (n = 100)...
July 15, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29991356/visit-to-visit-hba1c-variability-is-inversely-related-to-baroreflex-sensitivity-independently-of-hba1c-value-in-type-2-diabetes
#2
Daisuke Matsutani, Masaya Sakamoto, Soichiro Minato, Yosuke Kayama, Norihiko Takeda, Ryuzo Horiuchi, Kazunori Utsunomiya
BACKGROUND: The relationship between long-term glycemic variability (GV) represented by visit-to-visit HbA1c variability and baroreflex sensitivity (BRS) in type 2 diabetes mellitus (T2DM) has not been clarified by previous literature. The present study is the first to examine the relationships between visit-to-visit HbA1c variability and BRS. METHODS: This retrospective study initially analyzed data on 94 patients with T2DM. Visit-to-visit HbA1c variability was evaluated using the intrapersonal coefficient of variation (CV), standard deviation (SD), and adjusted SD of 8 or more serial measurements of HbA1c during a 2-year period...
July 10, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29991346/potential-mechanisms-responsible-for-cardioprotective-effects-of-sodium-glucose-co-transporter-2-inhibitors
#3
REVIEW
Sarayut Lahnwong, Siriporn C Chattipakorn, Nipon Chattipakorn
Diabetes mellitus currently affects over 350 million patients worldwide and is associated with many deaths from cardiovascular complications. Sodium-glucose co-transporter 2 (SGLT-2) inhibitors are a novel class of antidiabetic drugs with cardiovascular benefits beyond other antidiabetic drugs. In the EMPA-REG OUTCOME trial, empagliflozin significantly decreases the mortality rate from cardiovascular causes [38% relative risk reduction (RRR)], the mortality rate from all-causes (32% RRR) and the rate of heart failure hospitalization (35% RRR) in diabetic patients with established cardiovascular diseases...
July 10, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29981571/dual-inhibition-of-sodium-glucose-linked-cotransporters-1-and-2-exacerbates-cardiac-dysfunction-following-experimental-myocardial-infarction
#4
Kim A Connelly, Yanling Zhang, Jean-François Desjardins, Kerri Thai, Richard E Gilbert
BACKGROUND: Inhibiting both type 1 and 2 sodium-glucose linked cotransporter (SGLT1/2) offers the potential to not only increase glucosuria beyond that seen with selective SGLT2 inhibition alone but to reduce glucose absorption from the gut and to thereby also stimulate glucagon-like peptide 1 secretion. However, beyond the kidney and gut, SGLT1 is expressed in a range of other organs particularly the heart where it potentially assists GLUT-mediated glucose transport. Since cardiac myocytes become more reliant on glucose as a fuel source in the setting of stress, the present study sought to compare the effects of dual SGLT1/2 inhibition with selective SGLT2 inhibition in the normal and diseased heart...
July 7, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29981570/omega-3-polyunsaturated-fatty-acids-favourably-modulate-cardiometabolic-biomarkers-in-type-2-diabetes-a-meta-analysis-and-meta-regression-of-randomized-controlled-trials
#5
REVIEW
Lauren L O'Mahoney, Jamie Matu, Oliver J Price, Karen M Birch, Ramzi A Ajjan, Diane Farrar, Robyn Tapp, Daniel J West, Kevin Deighton, Matthew D Campbell
BACKGROUND: Randomized controlled trials (RCTs) suggest that supplementation with omega-3 polyunsaturated fatty acids (n-3PUFAs) may favourably modify cardiometabolic biomarkers in type 2 diabetes (T2DM). Previous meta-analyses are limited by insufficient sample sizes and omission of meta-regression techniques, and a large number of RCTs have subsequently been published since the last comprehensive meta-analysis. Updated information regarding the impact of dosage, duration or an interaction between these two factors is therefore warranted...
July 7, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29973202/interaction-between-endothelial-nitric-oxide-synthase-rs1799983-cholesteryl-ester-transfer-protein-rs708272-and-angiopoietin-like-protein-8-rs2278426-gene-variants-highly-elevates-the-risk-of-type-2-diabetes-mellitus-and-cardiovascular-disease
#6
Dalia El-Lebedy
BACKGROUND: The aim of the present study was to examine the association of angiopoietin-like proteins-8 (ANGPTL8) rs2278426, cholesteryl ester-transfer protein (CETP) rs708272 and endothelial nitric oxide synthase (NOS3) rs1799983 variants with type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD), and to investigate the effect of the potential interaction between these variants on disease risk. METHODS: Our study included 272 subjects classified into 68 patients with T2DM, 68 patients with T2DM complicated with CVD and 136 control subjects...
July 4, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29960591/prognostic-impact-of-hba1c-variability-on-long-term-outcomes-in-patients-with-heart-failure-and-type-2-diabetes-mellitus
#7
Jun Gu, Jian-An Pan, Yu-Qi Fan, Hui-Li Zhang, Jun-Feng Zhang, Chang-Qian Wang
BACKGROUND: The prognostic impact of long-term glycemic variability on clinical outcomes in patients with heart failure (HF) and type 2 diabetes mellitus (T2DM) remains unclear. We determined and compared hemoglobin A1c (HbA1c) variability and clinical outcomes for patients with HF with preserved ejection fraction (HFpEF), HF with mid-range ejection fraction (HFmrEF) and HF with reduced ejection fraction (HFrEF) in a prospective longitudinal study. METHODS: Patients with HF and T2DM, undergone 3 or more HbA1c determinations during the first 18 months, were then followed for 42 months...
June 30, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29960588/association-between-epicardial-adipose-tissue-high-sensitivity-c-reactive-protein-and-myocardial-dysfunction-in-middle-aged-men-with-suspected-metabolic-syndrome
#8
Dong-Hyuk Cho, Hyung Joon Joo, Mi-Na Kim, Do-Sun Lim, Wan Joo Shim, Seong-Mi Park
BACKGROUND: As body fat composition and metabolism differ between men and women, we evaluated sex-related differences in the association among epicardial adipose tissue (EAT), secretome profile, and myocardial function of subjects with suspected metabolic syndrome. METHODS: We evaluated 277 participants (men, n = 140; 56.1 ± 4.7 years) who underwent conventional echocardiography and two-dimensional speckle tracking from the Seoul Metabolic Syndrome cohort...
June 30, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29960584/actions-of-metformin-and-statins-on-lipid-and-glucose-metabolism-and-possible-benefit-of-combination-therapy
#9
REVIEW
Mariël F van Stee, Albert A de Graaf, Albert K Groen
Patients with diabetes type 2 have an increased risk for cardiovascular disease and commonly use combination therapy consisting of the anti-diabetic drug metformin and a cholesterol-lowering statin. However, both drugs act on glucose and lipid metabolism which could lead to adverse effects when used in combination as compared to monotherapy. In this review, the proposed molecular mechanisms of action of statin and metformin therapy in patients with diabetes and dyslipidemia are critically assessed, and a hypothesis for mechanisms underlying interactions between these drugs in combination therapy is developed...
June 30, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29945626/abdominal-subcutaneous-adipose-tissue-a-favorable-adipose-depot-for-diabetes
#10
Peizhu Chen, Xuhong Hou, Gang Hu, Li Wei, Lei Jiao, Hongmei Wang, Siyu Chen, Jingzhu Wu, Yuqian Bao, Weiping Jia
BACKGROUND: Previous studies have documented that visceral adipose tissue is positively associated with the risk of diabetes. However, the association of subcutaneous adipose tissue with diabetes risk is still in dispute. We aimed to assess the associations between different adipose distributions and the risk of newly diagnosed diabetes in Chinese adults. METHODS: The Shanghai Nicheng Cohort Study was conducted among Chinese adults aged 45-70 years. The baseline data of 12,137 participants were analyzed...
June 26, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29940978/associations-between-circulating-full-length-angiopoietin-like-protein-8-levels-and-severity-of-coronary-artery-disease-in-chinese-non-diabetic-patients-a-case-control-study
#11
Xiaolu Jiao, Jiqiang He, Yunyun Yang, Song Yang, Juan Li, Yanwen Qin
BACKGROUND: Angiopoietin-like protein 8 (ANGPTL8), which is a novel hormone produced in liver and adipose tissue, is involved in regulating lipid metabolism. Patients with diabetes and coronary artery disease (CAD) have remarkably higher levels of ANGPTL8 than those with only diabetes. However, no studies have investigated the involvement of ANGPTL8 in CAD in Chinese non-diabetic individuals. Therefore, we investigated full-length circulating ANGPTL8 levels in patients with CAD and the association between ANGPT8 levels and severity of CAD in Chinese individuals without diabetes...
June 25, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29935543/association-between-sodium-glucose-co-transporter-2-inhibitors-and-a-reduced-risk-of-heart-failure-in-patients-with-type-2-diabetes-mellitus-a-real-world-nationwide-population-based-cohort-study
#12
Young-Gun Kim, Seung Jin Han, Dae Jung Kim, Kwan-Woo Lee, Hae Jin Kim
BACKGROUND: Recently, two large randomized controlled trials which only included patients with underlying cardiovascular disease (CVD) or patients at high risk for CVD showed that two sodium glucose co-transporter 2 inhibitors (SGLT-2is) significantly reduced hospitalization for heart failure (hHF), with an early separation in the survival curves for hHF. There were concerns whether SGLT-2i use could protect hHF in patients without CVD and how soon SGLT-2i-treated patients show a lower risk of hHF...
June 23, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29907160/non-culprit-plaque-characteristics-in-acute-coronary-syndrome-patients-with-raised-hemoglobina1c-an-intravascular-optical-coherence-tomography-study
#13
Shaotao Zhang, Jiannan Dai, Haibo Jia, Sining Hu, Hongwei Du, Ning Li, Yongpeng Zou, Yanan Zou, Shenhong Jing, Yan Wang, Rong Sun, Bo Yu
BACKGROUND: Raised hemoglobinA1c (HbA1c) is an indicator of pre-diabetes, which is associated with increased risk of coronary artery disease. However, the detailed morphological characteristics of non-culprit plaques in acute coronary syndrome (ACS) patients remain largely unknown. METHODS: A total of 305 non-culprit plaques from 216 ACS patients were analyzed by intravascular optical coherence tomography. These patients were divided into three groups according to the serum glycosylated hemoglobin level: normal HbA1c (< 5...
June 15, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29903013/inhibition-of-calcium-calmodulin-dependent-kinase-ii-restores-contraction-and-relaxation-in-isolated-cardiac-muscle-from-type-2-diabetic-rats
#14
Lorna J Daniels, Rachel S Wallace, Olivia M Nicholson, Genevieve A Wilson, Fiona J McDonald, Peter P Jones, J Chris Baldi, Regis R Lamberts, Jeffrey R Erickson
BACKGROUND: Calcium/calmodulin-dependent kinase II-delta (CaMKIIδ) activity is enhanced during hyperglycemia and has been shown to alter intracellular calcium handling in cardiomyocytes, ultimately leading to reduced cardiac performance. However, the effects of CaMKIIδ on cardiac contractility during type 2 diabetes are undefined. METHODS: We examined the expression and activation of CaMKIIδ in right atrial appendages from non-diabetic and type 2 diabetic patients (n = 7 patients per group) with preserved ejection fraction, and also in right ventricular tissue from Zucker Diabetic Fatty rats (ZDF) (n = 5-10 animals per group) during early diabetic cardiac dysfunction, using immunoblot...
June 14, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29895330/rationale-and-design-of-study-of-dapagliflozin-versus-sitagliptin-treatment-efficacy-on-prevention-of-cardiovascular-risk-factors-in-type-2-diabetes-patients-the-diversity-cvr-study
#15
Fumika Shigiyama, Naoki Kumashiro, Ayako Fuchigami, Takahisa Hirose
BACKGROUND: Recent studies reported that sodium glucose cotransporter 2 (SGLT2) inhibitors reduced the cardiovascular morbidity and mortality in patients with type 2 diabetes mellitus (T2DM) compared to placebo in contrast to no reduction with dipeptidyl peptidase 4 (DPP4) inhibitors. However, there are no comparative studies on the effects of SGLT2 inhibitors and DPP4 inhibitors on HbA1c, body weight and hypoglycemia as risk factors of cardiovascular diseases. The aim of the present ongoing study is to compare the effects of dapagliflozin, a SGLT2 inhibitor, with those of sitagliptin, a DPP4 inhibitor, on cardiovascular risk factors in T2DM patients with inadequate glycemic control...
June 12, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29895299/association-between-abdominal-adiposity-and-subclinical-measures-of-left-ventricular-remodeling-in-diabetics-prediabetics-and-normal-controls-without-history-of-cardiovascular-disease-as-measured-by-magnetic-resonance-imaging-results-from-the-kora-ff4-study
#16
Christopher L Schlett, Roberto Lorbeer, Carolyn Arndt, Sigrid Auweter, Jürgen Machann, Holger Hetterich, Birgit Linkohr, Wolfgang Rathmann, Annette Peters, Fabian Bamberg
OBJECTIVES: Local, abdominal fat depots may be related to alterations in cardiac function and morphology due to a metabolic linkage. Thus, we aimed to determine their association with subtle cardiac changes and the potential interaction with hyperglycemic metabolic states. METHODS: Subjects from the general population and without history of cardiovascular disease were drawn from the Cooperative Health Research in the Region of Augsburg FF4 cohort and underwent 3 T cardiac and body MRI...
June 12, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29895294/comparing-the-inflammatory-profiles-for-incidence-of-diabetes-mellitus-and-cardiovascular-diseases-a-prospective-study-exploring-the-common-soil-hypothesis
#17
Xue Bao, Yan Borné, Linda Johnson, Iram Faqir Muhammad, Margaretha Persson, Kaijun Niu, Gunnar Engström
BACKGROUND: Chronic low-grade inflammation and associated insulin resistance and metabolic abnormalities have been proposed as 'common soil' for diabetes mellitus (DM) and cardiovascular disease (CVD). This paper aimed to investigate the inflammatory profiles of DM and CVD and to distinguish their shared and specific markers. METHODS: Based on the Malmö Diet and Cancer cohort, total and differential leukocyte counts were measured in 25,969 participants without previous DM or CVD and were studied in relation to incident DM (mean follow-up 17...
June 12, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29895290/clinical-application-of-glucagon-like-peptide-1-receptor-agonists-in-cardiovascular-disease-lessons-from-recent-clinical-cardiovascular-outcomes-trials
#18
EDITORIAL
Atsushi Tanaka, Koichi Node
Recent clinical trials investigating cardiovascular (CV) safety of newer antidiabetic agents have been rapidly and largely changing the landscape of diabetes care and providing highly important clinical information on decision-making regarding the choice of antidiabetic agents. Similar to the sodium-glucose cotransporter 2 (SGLT2) inhibitors, some glucagon-like peptide-1 receptor agonists (GLP-1RAs) have also demonstrated a marked risk reduction in major adverse CV events (MACE) in patients with type 2 diabetes at high risk of CV events...
June 12, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29884191/prevalence-of-cardiovascular-disease-in-type-2-diabetes-a-systematic-literature-review-of-scientific-evidence-from-across-the-world-in-2007-2017
#19
REVIEW
Thomas R Einarson, Annabel Acs, Craig Ludwig, Ulrik H Panton
BACKGROUND: Cardiovascular disease (CVD) is a common comorbidity in type 2 diabetes (T2DM). CVD's prevalence has been growing over time. PURPOSE: To estimate the current prevalence of CVD among adults with T2DM by reviewing literature published within the last 10 years (2007-March 2017). METHODS: We searched Medline, Embase, and proceedings of major scientific meetings for original research documenting the prevalence of CVD in T2DM. CVD included stroke, myocardial infarction, angina pectoris, heart failure, ischemic heart disease, cardiovascular disease, coronary heart disease, atherosclerosis, and cardiovascular death...
June 8, 2018: Cardiovascular Diabetology
https://www.readbyqxmd.com/read/29884175/skin-autofluorescence-predicts-major-adverse-cardiovascular-events-in-patients-with-type-1-diabetes-a-7-year-follow-up-study
#20
C Blanc-Bisson, F L Velayoudom-Cephise, A Cougnard-Gregoire, C Helmer, K Rajaobelina, C Delcourt, L Alexandre, L Blanco, K Mohammedi, M Monlun, V Rigalleau
BACKGROUND: Advanced glycation end-products play a role in diabetic vascular complications. Their optical properties allow to estimate their accumulation in tissues by measuring the skin autofluorescence (SAF). We searched for an association between SAF and major adverse cardiovascular events (MACE) incidence in subjects with Type 1 Diabetes (T1D) during a 7 year follow-up. METHODS: During year 2009, 232 subjects with T1D were included. SAF measurement, clinical [age, sex, body mass index (BMI), comorbidities] and biological data (HbA1C, blood lipids, renal parameters) were recorded...
June 8, 2018: Cardiovascular Diabetology
journal
journal
40195
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"